Agree Pr. It's all speculative atm based on previous data we use. The ratio between newly issued US IPO shares and the existing ASX total SOI can remain an open figure. Personally i feel (US) investors will favour less existing shares being carried over (to US IPO). Hence higher consolidation ratio is good for a successful US IPO and consequently bad for existing share holders. The good thing is with less total shares on issue (new+old) at Nasdaq if the following UH patient numbers and revenues are solid, then the SP will most likely rocket later (can apply a good P/E ratio like peers) regardless of initial IPO floor price, which will benefit all SHs in the end.
Hopefully we can see some released/confirmed August numbers and revenues before delisting as indicated, and GMV can board on nasdaq asap and avoid the tricky period of time (in US). Cheers
GMV Price at posting:
3.9¢ Sentiment: None Disclosure: Held
